Navigation Links
Amgen To Webcast 2013 Business Review Meeting On February 7
Date:1/31/2013

d the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com. Follow us on www.twitter.com/amgen.

Forward-Looking Statements
This news release contains forward-looking statements that involve significant risks and uncertainties, including those discussed below and others that can be found in our Form 10-K for the year ended Dec. 31, 2011, and in our periodic reports on Form 10-Q and Form 8-K. Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. 

No forward-looking statement can be guaranteed and actual results may differ materially from those we project. The Company's results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments (domestic or foreign) involving current and future products, sales growth of recently launched products, competition from other products (domestic or foreign) and difficulties or delays in manufacturing our products. In addition, sales of our products are affected by reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and health care cost containment as well as U.S. legislation affecting pharma
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
2. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
3. Amgen to Present at the Baird Growth Stock Conference
4. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
5. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
6. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
7. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
8. Amgen Completes Acquisition of KAI Pharmaceuticals
9. Amgens Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
10. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
11. Amgen To Present At The Baird Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... May 4, 2015 Former NASA scientist ... last week where he discussed Theradome™, the first portable ... The FOX segment shows firsthand how, via laser technology, ... loss solution that will not require surgery or medication.  ... at the base of the hair follicle, which is ...
(Date:5/4/2015)... and TORONTO , May 4, ... (OTCQB:GNBT) today announced that it intends to dividend to ... upon completion of a definitive licensing agreement to license ... ( www.smoofi.com ) (OTCQB:SMFI). As announced on ... of intent in respect of the licensing of its ...
(Date:5/4/2015)...  Impax Laboratories, Inc. (NASDAQ: IPXL ) announced ... appointing  Donna M. Hughes, as Senior Vice President, Human ... Vice President, Chief Compliance Officer. Both Ms. Hughes and ... Executive Officer, Fred Wilkinson . "We ... Impax team," said Fred Wilkinson , President and ...
Breaking Medicine Technology:FOX News Features Theradome as the Take-Home Solution to Tackle Baldness 2Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 2Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 3Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 4Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 5Impax Strengthens Leadership Team by Adding New Senior Vice Presidents for Human Resources and Compliance 2Impax Strengthens Leadership Team by Adding New Senior Vice Presidents for Human Resources and Compliance 3
... on complex cases, facility called ,future of hospital care, ... announces the opening of the Hamon Tower, the largest expansion ... intensive care for the region,s most critically ill patients. , ... new clinical programs for ICU patients, Hamon Tower is designed ...
... IRVINE, Calif., Oct. 2 ISTA Pharmaceuticals, Inc. (Nasdaq: ... financial results after market close on November 3, 2009. In ... p.m. Eastern Time to discuss these results and provide a ... , Time: 5:00 p.m. Eastern Time , Conference call ...
Cached Medicine Technology:Hamon Tower Features Critical Care Advances, Potential for Reduced Costs 2
(Date:5/4/2015)... Visiopharm, the leader in image analysis for diagnostic ... round of financing with NorthCap Partners . The ... Visiopharm to further accelerate business growth and strengthen their ... diagnostic digital pathology solutions. , "It has been exciting ... solution has energized the pathologists, and how fast we ...
(Date:5/4/2015)... 05, 2015 The National Association ... as a 2015-2016 inductee into its VIP Woman ... prestigious distinction for leadership in business. NAPW is the ... more than 700,000 members and over 200 operating Local ... important honor,” says NAPW President Star Jones. “Her perseverance, ...
(Date:5/4/2015)... NY (PRWEB) May 05, 2015 ... Elizabeth Moncada as a 2015-2016 inductee into ... is recognized with this prestigious distinction for leadership in ... exclusively for professional women, boasting more than 700,000 members ... to welcome Elizabeth into this exceptional group of professional ...
(Date:5/4/2015)... UK (PRWEB) May 04, 2015 During ... witness a 7.7% CAGR. Currently, the European and APAC ... world, while the North American probiotic market lags behind ... local population. , The North American probiotic market ... over 58%), followed by Canada and Mexico. The North ...
(Date:5/4/2015)... May 04, 2015 Malibu Biotech ... antiseptic breath spray. KissSafe™ is the first personal ... safer experience while adding fresh breath appeal. KissSafe™ ... effectively kills germs in the mouth and oral ... contains ingredients that possess additional wellness benefits. KissSafe’s ...
Breaking Medicine News(10 mins):Health News:Visiopharm Closes Investment Round to Grow Diagnostic Digital Pathology Business 2Health News:Visiopharm Closes Investment Round to Grow Diagnostic Digital Pathology Business 3Health News:NAPW Inducts Patti Hommes, Director of Advancement Services, Springside Chestnut Hill Academy, a 2015-2016 Professional Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Elizabeth Moncada, Owner, Moncada Center for Orofacial Pain, into its 2015-2016 VIP Woman of the Year Circle 2Health News:North America Probiotic Market to Increase by 2019, Announces MicroMarketMonitor in Its New Research Report Recently Published at MarketPublishers.com 2Health News:80 Million Germs from Kissing - Introducing KissSafe™ 2
... LONG BEACH, Calif., July 31, 2009 Raytheon ... patient tracking system to a public health-led team of first ... improve the availability of patient information. , ... the triage, treatment and transport of victims during mass casualty ...
... relieve stress, personal troubles, researchers caution, , FRIDAY, July ... Americans now have a positive opinion on psychiatric medications, ... of six people surveyed felt psychiatric medications could help ... medications could help people deal with day-to-day stresses, help ...
... LAWRENCE, Mass., July 31 NxStage Medical, Inc. (Nasdaq: ... today announced that Jeffrey H. Burbank, Chief Executive Officer, will be ... 11, 2009 at the InterContinental Hotel, Boston, MA. , ... 11th at 10:00 a.m. (EST). To listen to the audio ...
... EDWARDSVILLE, Ill., July 31 With the health care debate heating up in ... America might want to take a page from the Swiss playbook. , ... Switzerland has a mandate requiring everyone to be covered by ... to meet the mandate. , There is no employer-provided ...
... , , , SILVER SPRING, ... announced its results of operations for the quarter ended June 30, 2009. ... 2009 were $84.0 million, up from $68.6 million for the second quarter of ... share, for the second quarter of 2009, compared to net income of $12.1 ...
... ... Moran and Todd Tiahrt today released the following statement regarding the Government Accountability Office,s report ... research can be conducted as safely on the mainland as on Plum Island. , ... Washington, DC (Vocus) July 31, 2009 ...
Cached Medicine News:Health News:Raytheon to Provide California First Responders and Healthcare Personnel Electronic Patient Tracking System 2Health News:Psych Drugs Gaining Widespread Acceptance 2Health News:Psych Drugs Gaining Widespread Acceptance 3Health News:NxStage to Present at the Canaccord Adams Global Growth Conference 2Health News:Do the Swiss Have the Answer to America's Health Care Dilemma? 2Health News:Do the Swiss Have the Answer to America's Health Care Dilemma? 3Health News:United Therapeutics Corporation Reports Second Quarter 2009 Financial Results 2Health News:United Therapeutics Corporation Reports Second Quarter 2009 Financial Results 3Health News:United Therapeutics Corporation Reports Second Quarter 2009 Financial Results 4Health News:United Therapeutics Corporation Reports Second Quarter 2009 Financial Results 5Health News:United Therapeutics Corporation Reports Second Quarter 2009 Financial Results 6Health News:United Therapeutics Corporation Reports Second Quarter 2009 Financial Results 7Health News:United Therapeutics Corporation Reports Second Quarter 2009 Financial Results 8Health News:United Therapeutics Corporation Reports Second Quarter 2009 Financial Results 9Health News:Kansas Delegation: GAO Report Short on Expertise, Long on Errors; NBAF Critical to Protect Nation's Food Supply 2
... the only in-office test approved by the FDA ... BladderChek Test is a painless and non-invasive assay, ... elevated levels of NMP22 protein. Healthy individuals generally ... the urine. However, the level of NMP22 protein ...
Used for measuring rectal pressure during urodynamic studies. All-silicone construction provides maximum softness and biocompatibility for enhanced patient comfort. Supplied sterile in peel-open pack...
Used for suprapubic monitoring of bladder pressures. Suprapubic urodynamic studies avoid the effects of urethral catheterization and eliminate the need for a double bladder puncture. Supplied sterile...
... point-of-care (POC) diagnosis of patients with acute ... embolism. For use in doctors offices or ... counts, the Cardiac reader analyzer allows the ... D-Dimer from a single whole blood sample ...
Medicine Products: